Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y. | Pepdox

Home
Search
PMID 39222509

In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y.

Annals of internal medicine2024PMID: 39222509

View on PubMed DOI: 10.7326/ANNALS-24-01579-JC

Abstract

Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators.N Engl J Med. 2024;391:109-121. 38785209.

Authors

Collister, David; Pannu, Neesh